Get started
ASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)ASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)ASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)

ASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

AZND chart


Full chart

Key facts today

AstraZeneca is scheduled to announce its financial results next week, which may provide insights into the company's performance and market position.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪199.37 B‬ USD
Dividend yield (indicated)
1.75%
Price to earnings Ratio (TTM)
60.257
Basic EPS (TTM)
0.395 USD
Net income (FY)
‪2.17 B‬ USD
Revenue (FY)
‪16.68 B‬ USD
Shares float
—
Beta (1Y)
0.30

About ASTRAZENECA PLC ORD USD0.25


Sector
Health Technology
CEO
Pascal Soriot
Headquarters
Cambridge
Website
astrazeneca.co.uk
Founded
1992
ISIN
ARDEUT112489
FIGI
BBG000DDGBJ4
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AZND news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AZND highest yielding bonds


AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
5.18%
Maturity date
Sep 18, 2042
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
5.16%
Maturity date
Sep 15, 2037
US46353AM0
ASTRAZENECA PLC 15/45
Yield to maturity
5.16%
Maturity date
Nov 16, 2045
US46353AU2
ASTRAZENECA 18/48
Yield to maturity
5.14%
Maturity date
Aug 17, 2048
US46353AZ1
ASTRAZENECA 21/51
Yield to maturity
4.95%
Maturity date
May 28, 2051
A
US4636NAN3
ASTRAZEN.FI. 24/34
Yield to maturity
4.90%
Maturity date
Feb 26, 2034
US46353AX6
ASTRAZENECA 20/50
Yield to maturity
4.80%
Maturity date
Aug 6, 2050
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
4.76%
Maturity date
Mar 3, 2033
A
US4636NAM5
ASTRAZEN.FI. 24/31
Yield to maturity
4.72%
Maturity date
Feb 26, 2031
50UC
ASTRAZENECA PLC 5.75% SNR EMTN 13/11/2031
Yield to maturity
4.66%
Maturity date
Nov 13, 2031
A
AZN5193314
AstraZeneca Finance LLC 2.25% 28-MAY-2031
Yield to maturity
4.64%
Maturity date
May 28, 2031

Explore more bonds 

Sparks


Curated watchlists where AZND is featured.

See all sparks